HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eileen Francis

Reporter

Washington, DC
Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.

Latest From Eileen Francis

Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News

Coty and English footballer David Beckham announce a collection of eau de parfums rolling out to US retailers nationwide in January following a debut in JCPenney. Arcaea introduces biotech-based scents capturing the essence of extinct flowers, and Procter & Gamble’s Mielle hair-care brand launches its first ad campaign. More product launch and marketing news.

Launches Advertising, Marketing & Sales

FDA’s OTC Monograph User Fees Are Existential Threat To Small Contract Manufacturers, Cosmetics Brands

OMUFA reauthorization should include small business considerations for the US FDA’s OTC Monograph Drug User Fee Program, which established in 2020 a ‘one-size-fits-all’ facility and monograph order request user fee system which could lead to more contract manufacturer exits, a manufacturing bottleneck for OTC cosmetic products, and fewer product choices, says IBA.

FDA Regulation

US FTC Says It’s On ‘Solid Ground’ To Bring Cases Following Notices Of Penalty Offense

The US Federal Trade Commission is "fully prepared" to bring forward cases after issuing hundreds of penalty offense notices in April regarding health claims substantiation, and it is likely to seek injunctive and monetary relief, said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, at the National Advertising Division’s annual conference in Philadelphia.

Advertising, Marketing & Sales Enforcement

FTC On AI And Consumer Vulnerabilities: ‘One Self-Regulatory Failure Is Begetting Another’

The US FTC’s Sam Levine, director of the Bureau of Consumer Protection, discusses the advent of AI and the compounding risks consumers face in today’s evolving, largely unregulated, profoundly uncertain digital age.

Artificial Intelligence Business Strategies

NAD SWIFT Cases Get Swifter, More Frequent As Stakeholders Embrace Fast-Track Process

The BBB National Program Inc. expects to double the number of National Advertising Division SWIFT reviews completed in 2023 compared with last year as stakeholders grow more comfortable with the process. At its annual conference in Philadelphia 19-20 September, NAD said it is speeding up the time it takes to complete both SWIFT and standard track reviews.

Advertising, Marketing & Sales Regulation

Target Corp.'s ‘Clean’ Marketing Challenged In Consumer Class Action

The mega-retailer is defending a proposed class action in Minnesota federal court over its ‘Target Clean’ marketing and label, which it has awarded "independently" to around 4,000 products in its stores. Consumer plaintiffs allege some offerings contain ingredients on the program's “formulated without” list, as well as other hazardous substances that ought not be in clean products. Pending litigation against Sephora stands to be influential.

Advertising, Marketing & Sales Cosmetic Ingredients
See All
UsernamePublicRestriction

Register